Neuraxis

NRXSNYSE United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$75.912 M

$6.05 -11.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Neuraxis (NRXS) has a market capitalization of $75.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.57M

#3315 by revenue

Earnings

-$7.80M

Loss-making

Shares outstanding

12,557,765

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →

#15electroCoreECOR$82.0M
#16Outset MedicalOM$77.0M
#17NeuraxisNRXS$75.9M
#18HyperfineHYPR$72.6M
#19Precision OpticsPOCI$54.1M

What if Neuraxis were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,248,559

Per share 371,970× higher

Bitcoin $1.53T

$121,665.61

Per share 20,127× higher

Apple $5.02T

$399,416.83

Per share 66,074× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Neuraxis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.